BOCA RATON, Fla., Oct. 7, 2004 (PRIMEZONE) -- Sunwin International Neutraceuticals, Inc. (OTCBB:SUWN), a leading manufacturer of Chinese herbs, veterinary medicines and low calorie natural sweetener in China, announced today that the Company will launch a new veterinary medicine research project incorporating elements of Nanotechnology. Nanotechnology will be employed as a screen for active components of Chinese veterinary medicine.
There are certain active components which are fundamental for the effectiveness of any Chinese medicine. Our goal is to isolate such active components by using Nanotechnology. The new Nanotechnology-based technique will allow us to screen these active components in a nanometer level. Eventually we hope to be able to determine the precise levels of the primary active components in these Chinese medicines which can lead to reduced production costs for future Chinese veterinary medicine products.
The Company's CEO, Baozhong Yuan, noted, "We continue to devote resources to research and development. This latest project will seek to apply the advances of Nanotechnology in veterinary medicine. Our intent is to establish Sunwin as a leading firm in the research and production of Chinese veterinary medicine."
About Sunwin International Neutraceuticals, Inc.
Sunwin International Neutraceuticals, Inc. ("Sunwin") is engaged in the areas of essential traditional Chinese medicine, 100% organic herbal medicine, nutraceutical products, natural sweetener (beet sugar), and animal medicine prepared from 100% organic herbal ingredients. As an industry leader in agricultural processing, Sunwin has built an integrated global firm with the sourcing and production capabilities to meet the needs of consumers throughout the world. Sunwin also makes such value-added products as specialty veterinary food ingredients and specialty feed ingredients. The Sunwin family works closely with consumer to provide a quality, value, and a hybrid mix of agricultural products and services that meet growing demand. In 2002, Sunwin was recognized as one of the first 2,000 state-level companies that China authorized as the most important innovative high-tech pioneer businesses by the Chinese central government. In 2002, Sunwin was awarded as one of 2002 state-level biological product manufacturers in China. In 2003, Sunwin ranked as one of the top 50 companies of China Animal Related Health Care Product Pharmaceutical Industry. In 2003, Sunwin received award of Shandong Top-Ten Innovative, High-Tech Businesses by the Province Government of Shandong. For more information about Sunwin, please visit http://www.shengwang.com.
Safe Harbor Statement
Certain of the statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate," "project," "intend," "forecast," "anticipate," "plan," "planning," "expect," "believe," "will likely," "should," "could," "would," "may" or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited financial resources, domestic or global economic conditions -- especially those relating to China, activities of competitors and the presence of new or additional competition, and changes in Federal or State laws, restrictions and regulations on doing business in a foreign country, in particular China, and conditions of equity markets. More information about the potential factors that could affect the Company's business and financial results is included in the Company's filings, available via the United States Securities and Exchange Commission.